Alterations in Gut Microbiota and Immunity by Dietary Fat
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Gut microbiota play critical physiological roles in energy extraction from the intestine and in the control of systemic immunity, as well as local intestinal immunity. Disturbance of gut microbiota leads to the development of several diseases, such as colitis, inflammatorybowel diseases, metabolic disorders, cancer, etc. From a metabolic point of view, the gut is a large metabolic organ and one of the first to come into contact with dietary fats. Interestingly, excessive dietary fat has been incriminated as a primary culpritof metabolic syndrome and obesity. After intake of high-fat diet or Western diet, extensive changes in gut microbiota have been observed, which may be an underlying cause of alterations in whole body metabolism and nutrient homeostasis. Here, we summarizerecent data on changes in the gut microbiota and immunity associated with dietary fat, as well as their relationships with the pathogenesis of metabolic syndrome. These findings may provide insight into the understanding of the complex pathophysiologyrelated to the development of metabolic diseases and offer an opportunity to develop novel candidates for therapeutic agents.
Abstract
Gut microbiota play critical physiological roles in energy extraction from the intestine and in the control of systemic immunity, as well as local intestinal immunity. Disturbance of gut microbiota leads to the development of several diseases, such as colitis, inflammatorybowel diseases, metabolic disorders, cancer, etc. From a metabolic point of view, the gut is a large metabolic organ and one of the first to come into contact with dietary fats. Interestingly, excessive dietary fat has been incriminated as a primary culpritof metabolic syndrome and obesity. After intake of high-fat diet or Western diet, extensive changes in gut microbiota have been observed, which may be an underlying cause of alterations in whole body metabolism and nutrient homeostasis. Here, we summarizerecent data on changes in the gut microbiota and immunity associated with dietary fat, as well as their relationships with the pathogenesis of metabolic syndrome. These findings may provide insight into the understanding of the complex pathophysiologyrelated to the development of metabolic diseases and offer an opportunity to develop novel candidates for therapeutic agents.
참고문헌 (75)
- Beltrán-Sánchez H, "Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010", J Am Coll Cardiol, 62, pp.697~703 (2013)
- Hotamisligil GS, "Inflammation and metabolic disorders", Nature, 444, pp.860~867 (2006)
- Cani PD, "Metabolic endotoxemia initiates obesity and insulin resistance", Diabetes, 56, pp.1761~1772 (2007)
- Hill DA, "Intestinal bacteria and the regulation of immune cell homeostasis. Intestinal bacteria and the regulation of immune cell homeostasis", Annu Rev Immunol, 28, pp.623~667 (2010)
- Qin J, "A human gut microbial gene catalogue established by metagenomic sequencing", Nature, 464, pp.59~65 (2010)
- Nøhr MK, "GPR41", FFAR3 and GPR43, Endocrinology, pp.2013, 154[DOI]
- De Vadder F, "Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits", Cell, 156, pp.84~96 (2014)
- Delaere F, "The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing", Mol Metab, 2, pp.47~53 (2012)
- Plöger S, "Microbial butyrate and its role for barrier function in the gastrointestinal tract", Ann N Y Acad Sci, 1258, pp.52~59 (2012)
- Alenghat T, "Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis", Nature, 504, pp.153~157 (2013)
- Sealy L, "The effect of sodium butyrate on histone modification", Cell, 14, pp.115~121 (1978)
- Arpaia N, "Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation", Nature, 504, pp.451~455 (2013)
- Maslowski KM, "Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43", Nature, 461, pp.1282~1286 (2009)
- Perry RJ, "Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome", Nature, 534, pp.213~217 (2016)
- Cani PD, "Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal", Am J Clin Nutr, 90, pp.1236~1243 (2009)
- Bäckhed F, "The gut microbiota as an environmental factor that regulates fat storage", Proc Natl Acad Sci U S A, 101, pp.15718~15723 (2004)
- Bäckhed F, "Mechanisms underlying the resistance to diet-induced obesity in germfree mice", Proc Natl Acad Sci U S A, 104, pp.979~984 (2007)
- Turnbaugh PJ, "Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome", Cell Host Microbe, 3, pp.213~223 (2008)
- Turnbaugh PJ, "An obesity-associated gut microbiome with increased capacity for energy harvest", Nature, 444, pp.1027~1031 (2006)
- Woo PC, "Usefulness of the MicroSeq 500 16S ribosomal DNA-based bacterial identification system for identification of clinically significant bacterial isolates with ambiguous biochemical profiles", J Clin Microbiol, 41, pp.1996~2001 (2003)
- Ley RE, "Obesity alters gut microbial ecology", Proc Natl Acad Sci U S A, 102, pp.11070~11075 (2005)
- Krajmalnik-Brown R, "Effects of gut microbes on nutrient absorption and energy regulation", Nutr Clin Pract, 27, pp.201~214 (2012)
- Liu R, "Gut microbiome and serum metabolome alterations in obesity and after weightloss intervention", Nat Med, 23, pp.859~868 (2017)
- Cani PD, "Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice", Diabetes, 57, pp.1470~1481 (2008)
- Karlsson FH, "Gut metagenome in European women with normal, impaired and diabetic glucose control", Nature, 498, pp.99~103 (2013)
- Qin J, "A metagenome-wide association study of gut microbiota in type 2 diabetes", Nature, 490, pp.55~60 (2012)
- Quévrain E, "Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease", Gut, 65, pp.415~425 (2016)
- Choi Y, "Gut microbe-derived extracellular vesicles induce insulin resistance, thereby impairing glucose metabolism in skeletal muscle", Sci Rep, 5, pp.15878~ (2015)
- Kovatcheva-Datchary P, "Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of prevotella", Cell Metab, 22, pp.971~982 (2015)
- Wu GD, "Linking long-term dietary patterns with gut microbial enterotypes", Science, 334, pp.105~108 (2011)
- Karlsson CL, "The microbiota of the gut in preschool children with normal and excessive body weight", Obesity (Silver Spring), 20, pp.2257~2261 (2012)
- Santacruz A, "Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women", Br J Nutr, 104, pp.83~92 (2010)
- Caesar R, "Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling", Cell Metab, 22, pp.658~668 (2015)
- Schneeberger M, "Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice", Sci Rep, 5, pp.16643~ (2015)
- Devkota S, "Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-", - mice, 2012, pp.487, 104~108
- Collado MC, "Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly", Appl Environ Microbiol, 73, pp.7767~7770 (2007)
- Everard A, "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity", Proc Natl Acad Sci U S A, 110, pp.9066~9071 (2013)
- Shin NR, "An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice", Gut, 63, pp.727~735 (2014)
- Chevalier C, "Gut microbiota orchestrates energy homeostasis during cold", Cell, 163, pp.1360~1374 (2015)
- Dao MC, "Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology", Gut, 65, pp.426~436 (2016)
- Liou AP, "Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity", Sci Transl Med, 5, pp.178~ (2013)
- Li J, "Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe-", - mice, 2016, pp.133, 2434~2446
- Lee H, "Effect of metformin on metabolic improvement and gut microbiota", Appl Environ Microbiol, 80, pp.5935~5943 (2014)
- Cabreiro F, "Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism", Cell, 153, pp.228~239 (2013)
- de la Cuesta-Zuluaga J, "Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut", Diabetes Care, 40, pp.54~62 (2017)
- Wu H, "Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug", Nat Med, 23, pp.850~858 (2017)
- Plovier H, "A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice", Nat Med, 23, pp.107~113 (2017)
- Suzuki T, "Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats", Nutr Metab (Lond), 7, pp.19~ (2010)
- Shi H, "TLR4 links innate immunity and fatty acid-induced insulin resistance", J Clin Invest, 116, pp.3015~3025 (2006)
- Vandanmagsar B, "The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance", Nat Med, 17, pp.179~188 (2011)
- Wen H, "Fatty acidinduced NLRP3-ASC inflammasome activation interferes with insulin signaling", Nat Immunol, 12, pp.408~415 (2011)
- Cario E, "Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors", J Immunol, 164, pp.966~972 (2000)
- Chung H, "NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis", Cell Death Differ, 23, pp.1331~1346 (2016)
- Everard A, "Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status", Nat Commun, 5, pp.5648~ (2014)
- Vijay-Kumar M, "Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5", Science, 328, pp.228~231 (2010)
- Chassaing B, "Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice", Gastroenterology, 147, pp.1363~1377 (2014)
- Singh V, "Microbiota-dependent hepatic lipogenesis mediated by stearoyl CoA desaturase 1 (SCD1) promotes metabolic syndrome in TLR5-deficient mice", Cell Metab, 22, pp.983~996 (2015)
- Brestoff JR, "Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity", Nature, 519, pp.242~246 (2015)
- Lee MW, "Activated type 2 innate lymphoid cells regulate beige fat biogenesis", Cell, 160, pp.74~87 (2015)
- Luck H, "Regulation of obesity-related insulin resistance with gut anti-inflammatory agents", Cell Metab, 21, pp.527~542 (2015)
- Wang X, "Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes", Nature, 514, pp.237~241 (2014)
- Gross M, "Guardians of the gut -murine intestinal macrophages and dendritic cells", Front Immunol, 6, pp.254~ (2015)
- Garidou L, "The gut microbiota regulates intestinal CD4 T cells expressing RORγt and controls metabolic disease", Cell Metab, 22, pp.100~112 (2015)
- Hong CP, "Gutspecific delivery of T-helper 17 cells reduces obesity and insulin resistance in mice", Gastroenterology, 152, pp.1998~2010 (2017)
- Monteiro-Sepulveda M, "Jejunal T cell inflammation in human obesity correlates with decreased enterocyte insulin signaling", Cell Metab, 22, pp.113~124 (2015)
- Gaublomme JT, "Single-cell genomics unveils critical regulators of Th17 cell pathogenicity", Cell, 163, pp.1400~1412 (2015)
- Lee Y, "Induction and molecular signature of pathogenic TH17 cells", Nat Immunol, 13, pp.991~999 (2012)
- Wagner N, "Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue", Nature, 382, pp.366~370 (1996)
- Williams MB, "Homing of naive and memory T lymphocyte subsets to Peyer’s patches, lymph nodes, and spleen", J Immunol, 159, pp.1746~1752 (1997)
- Kinugasa T, "Claudins regulate the intestinal barrier in response to immune mediators", Gastroenterology, 118, pp.1001~1011 (2000)
- Cani PD, "Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia", Diabetologia, 50, pp.2374~2383 (2007)
- Desai MS, "A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility", Cell, 167, pp.1339~1353 (2016)
- Chassaing B, "Lack of soluble fiber drives diet-induced adiposity in mice", Am J Physiol Gastrointest Liver Physiol, 309, pp.G528~G541 (2015)
- Amar J, "Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment", EMBO Mol Med, 3, pp.559~572 (2011)
- Lakhan SE, "Gut microbiota and sirtuins in obesityrelated inflammation and bowel dysfunction", J Transl Med, 9, pp.202~ (2011)
